Invitrogen, ABI to be Named Life Technologies Post-Merger | GenomeWeb
This article has been updated to include confirmation from an Invitrogen official.
 
NEW YORK (GenomeWeb News) – Following the merger of Invitrogen and Applied Biosystems, which is expected to close this month, the combined entity will be named Life Technologies, according to an internal memo from Invitrogen Chairman and CEO Greg Lucier to employees obtained by GenomeWeb Daily News.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.